Dysregulation of IL-33 and its receptor signaling have been strongly implicated in a variety of inflammatory diseases, including IBD [13,14,15,16], highlighting this cytokine as a critical molecule of mucosal immunity. The gene discussed is IL33; the disease is inflammatory bowel disease.